First-line lenvatinib (Len) plus pembrolizumab (Pembro) plus chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in Meeting Abstract
| Authors: | Shitara, K.; Ben-Aharon, I.; Rojas, C.; Eyzaguirre, D. A. A.; Hubert, A.; Moya, H. A.; Cohen, D.; Bai, L. Y.; Ghiringhelli, F.; Wyrwicz, L.; Janjigian, Y. Y.; Tabernero, J.; Van Cutsem, E.; Qin, S.; Xu, J.; Wang, A.; Miller, M. G.; Shih, C. S.; Bhagia, P.; Weber, P. E. Y. |
| Abstract Title: | First-line lenvatinib (Len) plus pembrolizumab (Pembro) plus chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in |
| Meeting Title: | Annals of Oncology |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1108 |
| Language: | English |
| ACCESSION: | WOS:000866211601484 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.annonc.2022.07.1341 |
| Notes: | Meeting Abstract: 1223P -- Source: Wos |
